Perspective Therapeutics Inc.
Perspective Therapeutics, Inc., together with its subsidiaries, develops and commercializes precision targeted alpha therapies (TAT) to treat cancer in the United States. The company discovers, and develop its initial drug candidate VMT-a-NET that is in Phase 1/2a clinical trials for patients with unresectable or metastatic somatostatin receptor type 2 (SSTR2)-expressing neuroendocrine tumors tha… Read more
Perspective Therapeutics Inc. (CATX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.067x
Based on the latest financial reports, Perspective Therapeutics Inc. (CATX) has a cash flow conversion efficiency ratio of -0.067x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-16.29 Million) by net assets ($242.22 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Perspective Therapeutics Inc. - Cash Flow Conversion Efficiency Trend (1994–2024)
This chart illustrates how Perspective Therapeutics Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Perspective Therapeutics Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Perspective Therapeutics Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SNTEnergy Co Ltd
KO:100840
|
0.050x |
|
Cosmo Chem
KO:005420
|
0.054x |
|
Novogene Co. Ltd.
SHG:688315
|
0.036x |
|
Zhongjin Irradiation Incorporated Company
SHE:300962
|
0.046x |
|
Hubei Yingtong Telecommunication Cable Co Ltd
SHE:002861
|
0.023x |
|
Thai Airways International Public Company Limited
PINK:TAWNF
|
0.011x |
|
Shandong Astro-century Education&Technology Co Ltd
SHE:300654
|
0.023x |
|
Changzhou Kaidi Electrical Inc
SHG:605288
|
-0.020x |
Annual Cash Flow Conversion Efficiency for Perspective Therapeutics Inc. (1994–2024)
The table below shows the annual cash flow conversion efficiency of Perspective Therapeutics Inc. from 1994 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $290.67 Million | $-18.29 Million | -0.063x | +87.18% |
| 2023-12-31 | $75.18 Million | $-36.91 Million | -0.491x | -120.42% |
| 2023-06-30 | $54.64 Million | $-12.17 Million | -0.223x | 0.00% |
| 2022-12-31 | $54.64 Million | $-12.17 Million | -0.223x | -77.04% |
| 2022-06-30 | $61.28 Million | $-7.71 Million | -0.126x | 0.00% |
| 2021-12-31 | $61.28 Million | $-7.71 Million | -0.126x | -198.95% |
| 2021-06-30 | $67.41 Million | $-2.84 Million | -0.042x | +81.05% |
| 2020-12-31 | $12.77 Million | $-2.84 Million | -0.222x | +65.09% |
| 2020-06-30 | $5.72 Million | $-3.64 Million | -0.636x | 0.00% |
| 2019-12-31 | $5.72 Million | $-3.64 Million | -0.636x | +3.23% |
| 2019-06-30 | $7.68 Million | $-5.05 Million | -0.657x | 0.00% |
| 2018-12-31 | $7.68 Million | $-5.05 Million | -0.657x | +42.11% |
| 2018-06-30 | $5.03 Million | $-5.71 Million | -1.136x | -110.78% |
| 2017-12-31 | $10.60 Million | $-5.71 Million | -0.539x | 0.00% |
| 2017-06-30 | $10.60 Million | $-5.71 Million | -0.539x | -127.51% |
| 2016-12-31 | $16.40 Million | $-3.88 Million | -0.237x | 0.00% |
| 2016-06-30 | $16.40 Million | $-3.88 Million | -0.237x | -39.74% |
| 2015-12-31 | $20.78 Million | $-3.52 Million | -0.169x | 0.00% |
| 2015-06-30 | $20.78 Million | $-3.52 Million | -0.169x | -25.76% |
| 2014-12-31 | $23.96 Million | $-3.23 Million | -0.135x | 0.00% |
| 2014-06-30 | $23.96 Million | $-3.23 Million | -0.135x | +76.34% |
| 2013-12-31 | $5.37 Million | $-3.06 Million | -0.570x | 0.00% |
| 2013-06-30 | $5.37 Million | $-3.06 Million | -0.570x | -35.37% |
| 2012-12-31 | $5.82 Million | $-2.45 Million | -0.421x | 0.00% |
| 2012-06-30 | $5.82 Million | $-2.45 Million | -0.421x | -12.23% |
| 2011-12-31 | $6.45 Million | $-2.42 Million | -0.375x | 0.00% |
| 2011-06-30 | $6.45 Million | $-2.42 Million | -0.375x | +13.54% |
| 2010-12-31 | $6.20 Million | $-2.69 Million | -0.434x | 0.00% |
| 2010-06-30 | $6.20 Million | $-2.69 Million | -0.434x | -9.39% |
| 2009-12-31 | $9.96 Million | $-3.95 Million | -0.396x | 0.00% |
| 2009-06-30 | $9.96 Million | $-3.95 Million | -0.396x | +19.06% |
| 2008-12-31 | $15.77 Million | $-7.73 Million | -0.490x | 0.00% |
| 2008-06-30 | $15.77 Million | $-7.73 Million | -0.490x | -54.47% |
| 2007-12-31 | $22.72 Million | $-7.20 Million | -0.317x | 0.00% |
| 2007-06-30 | $22.72 Million | $-7.20 Million | -0.317x | +86.94% |
| 2006-12-31 | $2.89 Million | $-7.00 Million | -2.427x | 0.00% |
| 2006-06-30 | $2.89 Million | $-7.00 Million | -2.427x | -276434.01% |
| 2005-06-30 | $11.23 Million | $-9.86K | -0.001x | +99.71% |
| 2004-12-31 | $11.23 Million | $-3.39 Million | -0.301x | -994.03% |
| 2004-06-30 | $-564.20K | $-19.02K | 0.034x | +311.89% |
| 2003-12-31 | $-1.08 Million | $-8.87K | 0.008x | 0.00% |
| 2003-06-30 | $-1.08 Million | $-8.87K | 0.008x | -42.63% |
| 2002-12-31 | $-1.03 Million | $-14.73K | 0.014x | +98.69% |
| 2002-06-30 | $-1.03 Million | $-7.42K | 0.007x | +24.19% |
| 2001-12-31 | $-1.28 Million | $-7.42K | 0.006x | +101.94% |
| 2000-12-31 | $-1.22 Million | $365.34K | -0.298x | -130.95% |
| 1999-12-31 | $-2.14 Million | $275.97K | -0.129x | +42.68% |
| 1999-06-30 | $-1.22 Million | $275.97K | -0.225x | -4087.12% |
| 1998-12-31 | $-2.07 Million | $-11.71K | 0.006x | +3.08% |
| 1998-06-30 | $-2.14 Million | $-11.71K | 0.005x | -99.04% |
| 1997-12-31 | $-1.90 Million | $-1.08 Million | 0.569x | +8.88% |
| 1997-06-30 | $-2.07 Million | $-1.08 Million | 0.523x | -32.96% |
| 1996-12-31 | $-643.46K | $-501.83K | 0.780x | +195.70% |
| 1996-06-30 | $-1.90 Million | $-501.83K | 0.264x | +115.05% |
| 1995-12-31 | $295.71K | $-518.19K | -1.752x | -317.59% |
| 1995-06-30 | $-643.46K | $-518.19K | 0.805x | +145.96% |
| 1994-06-30 | $295.71K | $-518.19K | -1.752x | -- |